For the Inventor, By the Inventor

Enter assignee name

Santa Monica, CA, United States of America

Agensys, Inc.

USPTO Granted Patents = 199

% Expired Patents = 50.8

CIPO Patents = 13

EPO Patents = 32

Trademarks = 3

Forward Citations = 1,302

Loading Chart...

Loading Chart...

61 inventors (with patents filed for the assignee):

Arthur B Raitano (158 out of 164 patents)

Aya Jakobovits (151 out of 191 patents)

Pia M Challita-Eid (113 out of 113 patents)

4. Rene S Hubert (110 out of 116 patents)

5. Mary Faris (99 out of 104 patents)

6. Karen Jane Meyrick Morrison (68 out of 68 patents)

7. Wangmao Ge (68 out of 68 patents)

8. Robert Kendall Morrison (62 out of 62 patents)

9. Daniel E H Afar (55 out of 56 patents)

10. Douglas C Saffran (34 out of 41 patents)

11. Jean M Gudas (33 out of 49 patents)

12. Xiao-Chi Jia (26 out of 57 patents)

13. Daniel E Afar (25 out of 36 patents)

14. Juan J Perez-Villar (23 out of 26 patents)

15. Steve Chappell Mitchell (22 out of 22 patents)

Core Competencies:

Antibody Drug Conjugates

AXL Proteins

CD37 Proteins

FLT3 Proteins

Nucleic Acid Molecules

Tumor Associated Proteins

Prostate Cancer

Cancer Detection

199 patents: Sort by Forward Citations

1. 12612429 - Derivatives of dolaproine-dolaisoleuine peptides (2026-04-28),

2. 12552868 - ANTIBODIES THAT BIND TO AXL PROTEINS (2026-02-17),

3. 12545737 - ANTIBODIES THAT BIND TO AXL PROTEINS (2026-02-10),

4. 12257340 - Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof (2025-03-25),

5. 11739155 - Antibodies that bind to AXL proteins (2023-08-29),

6. 11718677 - Antibodies that bind to AXL proteins (2023-08-08),

7. 11634503 - Antibody drug conjugates (ADC) that bind to 158P1D7 proteins (2023-04-25),

8. 11633500 - Antibody drug conjugates (ADC) that bind to CD37 proteins (2023-04-25),

9. 11559582 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins (2023-01-24),

10. 11401347 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins (2022-08-02),

11. 11312748 - Derivatives of dolaproine-dolaisoleucine peptides (2022-04-26),

12. 11292837 - Nectin-4 binding proteins and methods of use thereof (2022-04-05),

13. 10894090 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins (2021-01-19),

14. RE48389 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins (2021-01-11),

15. 10787517 - Antibodies that bind to AXL proteins (2020-09-29),

Agensys, Inc., based in Santa Monica, CA, specializes in the development of innovative antibody drug conjugates (ADCs) aimed at treating various cancers. The company focuses on leveraging its expertise in AXL, CD37, and FLT3 proteins, along with nucleic acid molecules and tumor-associated proteins, to advance cancer detection and therapeutic strategies. Agensys is dedicated to addressing unmet medical needs in oncology, particularly in prostate cancer, through its cutting-edge research and technology initiatives.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

199 Patents

#4 in Santa Monica, CA

#453 in California

#2,070 in US

#4,236 in the World

Santa Monica, CA, United States of America

Agensys, Inc.

Forward Citations = 1,302

61 inventors:

Arthur B Raitano (158 out of 164 patents)

Aya Jakobovits (151 out of 191 patents)

Pia M Challita-Eid (113 out of 113 patents)

4. Rene S Hubert (110 out of 116 patents)

5. Mary Faris (99 out of 104 patents)

Please report any incorrect information to [email protected]

Loading…